PIP and breast cancer: Given that patients have a history of breast cancer, 2 breasts specific markers, GATA3 (−), GCDFP-15 (−), and ER (−), PR (−), combined with the pathological form of patients with primary breast tumors and hormone receptor status, the recurrence and metastasis of breast cancer was excluded.